- Evaluating how fast the delivery technology field has evolved until now – are there limiting factors to its continued development?
- What is the potential of less-traditional delivery routes such as nasal and ocular delivery?
- Discussing the future of evolving areas including polymer technologies, auto injectors, microneedles etc.
- Looking retrospectively, has the industry done all it can until now to maintain the R&D paradigm?
Anand Subramony, Vice President Novel Product Technologies, MedImmune